Um 18 Uhr geht's los: Jahresendrally - auf welche Aktien sollten Sie setzen? Jetzt kostenlos anmelden!
28.09.2021 23:57

Circuit Clinical Launches the Participant Engagement Council to Elevate the Participant Voice and Transform Access to Clinical Trials for Diverse Communities

Folgen
Werbung

BUFFALO, N.Y., Sept. 28, 2021 /PRNewswire/ -- Circuit Clinical is proud to announce the launch of their Participant Engagement Council, composed of both national leaders in the clinical trials industry and community engagement. The Council's mandate is to guide Circuit Clinical's actions to increase clinical trials access and awareness, with a specific focus on diversity, equity, and inclusion (DEI), patient advocacy, and outreach into diverse communities.

Circuit Clinical Logo (PRNewsfoto/Circuit Clinical)

"The Council reflects Circuit Clinical's core value of Expansive Inclusion," noted CEO Dr. Irfan Khan. "I'm honored to engage with and learn from such an incredibly talented group of experts as we work to create clinical trial opportunities for diverse communities across the country."

The Participant Engagement Council's Co-Chairs are Jordyne Blaise, most recently Director of Diversity, Equity, and Inclusion at Bluebird Bio, and Thomas Quinn, CEO of the Western New York Impact Investment Fund and a former senior executive of The Medicines Company. Members of the Council include leaders with expertise in delivering care to diverse communities and patient advocacy: Dr. LaVonne Ansari, Dr. Kenyani Davis, Fatima Mathews, Carol Nottingham, and Kathy Spillman.

"The Council has a unique opportunity to create more and better opportunities for communities of color and other underrepresented groups to access clinical trials. The Council is grounded on a simple premise – this convening of incredible advocates and community leaders will provide indelible insights and propel Circuit Clinical and its partners to provide historically marginalized communities with greater standards of care," said Jordyne Blaise, Co-Chair of the Participant Engagement Council.

"The Participant Engagement Council significantly expands Circuit Clinical's ability to provide equal access to clinical trials for all through its increased commitment to diversity, equity, and inclusion. I am proud to serve as Co-Chair of this Council and look forward to advancing the important work of Circuit Clinical, one of the Western New York Impact Investment Fund's portfolio companies that works every day to increase medical access for every individual in our region and beyond," said Thomas P. Quinn, CEO, Western New York Impact Investment Fund.

"As Circuit Clinical's Patient Advocate Manager, I am proud to be part of this initiative," said Carol Nottingham. "The underrepresentation of certain communities within research is an obstacle that is ripe for change. We are committed to this endeavor and to bear witness to a time when being in a research study will be endorsed as a viable health care option for all."

Learn more about Circuit Clinical's mission: https://www.circuitclinical.com/ 

About Circuit Clinical: 
Circuit Clinical®, one of the largest integrated research organizations in the USA, is dedicated to empowering patients to choose clinical research as a care option. Circuit Clinical® is committed to transforming the way physicians and their patients find, conduct, and participate in clinical research. They deliver clinical research services and an award-winning patient engagement platform, trialjourney.com.

Follow Circuit Clinical on Facebook, LinkedIn, Instagram, and Twitter.

Contact: Rachel Ernisse, rernisse@circuitclinical.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/circuit-clinical-launches-the-participant-engagement-council-to-elevate-the-participant-voice-and-transform-access-to-clinical-trials-for-diverse-communities-301387279.html

SOURCE Circuit Clinical

Um 18 Uhr live: Jahresendrally - auf welche Aktien sollten Sie setzen?

Trotz eines vergleichsweise schwachen Marktes rechnen Experten mit einer intensiven Jahresendrally. Die Frage aller Fragen ist nun: Wer sind die Favoriten für 2022? Im Onine-Seminar heute ab 18 Uhr geben Ihnen Jürgen Schmitt und Mick Knauff einen exklusiven Ausblick.
Jetzt noch kostenlos anmelden!
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX an Nulllinie -- Asiens Börsen in Grün -- SEC entlastet GameStop-Shortseller -- Software AG senkt Ausblick für Digital -- Delivery Hero steigt bei Gorillas ein -- BHP im Fokus

Ericsson setzt weniger um als erwartet - Operativer Gewinn überrascht positiv. Danone kann Drittquartalsumsatz steigern und bestätigt Jahresprognose. USA überarbeiten Sanktionspolitik - Risiko durch Bitcoin & Co. Apple will mit neuen M1-Chips PC-Markt aufrollen. TeamViewer-Aktie unter Druck: Keine positive Wende bei TeamViewer.

Umfrage

Wo steht der DAX zum Jahresende?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln